COLUMBIA, SC--(Marketwire - August 16, 2010) -
Highlighted Links |
|
|
BDI Pharma, Inc. (BDI), the nation’s fastest growing national distributor of biotech therapies, announced the successful launch of its proprietary on-line ordering system. The system, initially rolled out earlier this month, provides BDI’s customers with the ability to place specialty pharmaceutical purchases on-line via the internet through a secure, facility-individualized ordering portal.
“We felt it was important to provide an on-line option that incorporated BDI Pharma’s customer centric service model to ensure that we could effectively combine ease of ordering with personal responsiveness,” stated Claude Ferry, Vice President, Sales. “BDI prides itself on affording our customers, our partners, with as much contact and interaction as they need to make their purchasing decisions. Whether it is through the simple click of a mouse or through personal interaction with a BDI representative, the value that BDI offers to those who utilize our services will always be worthy of the hard-earned reputation we have with our customers nationwide and the industry as a whole.”
The company’s on-line ordering portal is available to healthcare providers that have an active account with BDI and may be accessed on the company’s corporate home page, www.bdipharma.com. If a facility does not have a current active account with the company, it is as simple as contacting BDI Pharma at orders@bdipharma.com to update a latent account or establish a new one.
About BDI Pharma, Inc.
Since 1995, BDI Pharma, Inc. (formerly known as Blood Diagnostics, Inc.) has built an exceptional reputation as the industry trusted source for products and service. The company has exhibited an exemplary track record providing an unparalleled level of customer service, market data and product integrity to both its customer base and trade partners. Such commitment to the product channel has earned BDI recognition as “ADR,” or Authorized Distributor of Record, for the manufacturers it represents. BDI’s specialty pharmaceutical focus is evident in its commitment to biotherapeutics, chemotherapies, vaccines and plasma protein therapies, including albumin, IVIG, coagulation factors, high-titer immune globulins, and injectables.
BDI Pharma defines its customer-centric approach to serving the nation’s healthcare community through innovative inventory supply solutions, unparalleled customer service, extensive product knowledge, 24/7 emergency availability and urgent need delivery. An open-access resource for reference material, educational literature, market data and online ordering, BDI Pharma’s home web page www.bdipharma.com has become an industry renowned point of reference. Proprietary programs for product consignment (www.consignadvantage.com), influenza vaccine pre-booking (www.securiflu.com), vaccine ordering (www.securivax.com) and purchasing/reward programs (www.qoreprogram.com and www.securigam.com) round out a family of solutions tailored to the needs of the healthcare community at large.
Contact:
Brad Davis
Assistant Vice President, Marketing
Email Contact
(800) 948-9834